Hemp Industries Association v. Drug Enforcement Administration

Last updated

Hemp Industries Association v. Drug Enforcement Administration, often shortened to HIA v. DEA, refers to two lawsuits concerning the legality of cannabis extracts and other products from the hemp plant that have very low or nonexistent natural THC levels, including CBD oil, in the United States. The first is from 2004 and the second is from 2018.

Contents

2004 Case

In the 2004 case the 9th Circuit Court of Appeals established that the DEA had made illegal regulations intended to implement laws creating separate legal regimes for marijuana and THC. The court found the DEA's rules infringed upon legal trade in parts of the hemp plant exempted from regulation by Congress and against the will of Congress when Congress passed the marijuana and THC related legislation. [1]

Specifically, the DEA chose to ban trade parts of the hemp plant legally exempted from the definition of "marihuana" by using THC related legislation. The THC legislation was passed without repealing the marijuana legislation superficially creating two contradictory legal regimes for the same substance. When the court looked into the history of the legislation, the court found Congress was attempting to ban synthetic THC which had recently been synthesized in a lab. Because Congress chose not to repeal the marijuana legislation with the exemptions, the court concluded that the natural plant was intended to be covered by the marijuana legislation and the synthetic lab derived THC was intended to be banned by the THC legislation. [1]

The court further found that even if it regulation was legal, the DEA didn't follow the Congressionally mandated process for a federal agency to create regulations to implement laws so the regulations were struck down. [1]

2018 Case

In 2018 Hemp Industries Association alleged the DEA for created and was enforcing a similar regulation to the one that the ninth circuit court of appeals struck down in 2004. The parties reached a settlement in which the DEA would clarify the new regulation in light of certain Congressional Acts and the Ninth Circuits previous ruling and distribute this statement to the public and its partner agencies that the plaintiff alleges were violating the 2004 ruling.

The plaintiff, Hemp Industries Association (HIA) claimed that CBD is not regulated by the Controlled Substances Act; the Drug Enforcement Administration took steps in December, 2016 to index "marihuana extract" as a substance under its purview, with code number 7350. [2] [3] [4] Part of the legal challenge stipulates that the DEA's action contravenes the Agricultural Act of 2014 (also called the 2014 Farm Bill) which allows hemp farming under certain conditions. [5] After the lawsuit was begun a public statement was released. It started "Because [of] recent public inquiries that DEA has received following the publication of the Final Rule suggest[ing] there may be some misunderstanding about the source of cannabinoids in the cannabis plant", the DEA issued a clarification of the code which stated it did not apply to products derived from "parts of the cannabis plant excluded from the CSA definition of marijuana, such as the flowering tops, resin, and leaves". [6]

The 9th Circuit Court of Appeals heard the case in February, 2018. [7] A number of members of the U.S. Congress filed an amicus brief supporting HIA. [8]

Related Research Articles

<span class="mw-page-title-main">Marihuana Tax Act of 1937</span> American law placing a tax on cannabis

The Marihuana Tax Act of 1937, Pub. L. 75–238, 50 Stat. 551, enacted August 2, 1937, was a United States Act that placed a tax on the sale of cannabis. The H.R. 6385 act was drafted by Harry Anslinger and introduced by Rep. Robert L. Doughton of North Carolina, on April 14, 1937. The Seventy-fifth United States Congress held hearings on April 27, 28, 29th, 30th, and May 4, 1937. Upon the congressional hearings confirmation, the H.R. 6385 act was redrafted as H.R. 6906 and introduced with House Report 792. The Act is now commonly referred to, using the modern spelling, as the 1937 Marijuana Tax Act. This act was overturned in 1969 in Leary v. United States, and was repealed by Congress the next year.

<span class="mw-page-title-main">Cannabidiol</span> Phytocannabinoid discovered in 1940

Cannabidiol (CBD) is a phytocannabinoid discovered in 1940. It is one of 113 identified cannabinoids in cannabis plants, along with tetrahydrocannabinol (THC), and accounts for up to 40% of the plant's extract. As of 2019, clinical research on CBD included studies related to anxiety, cognition, movement disorders, and pain, but there is insufficient high-quality evidence that cannabidiol is effective for these conditions. Nevertheless, CBD is a herbal dietary supplement promoted with unproven claims of particular therapeutic effects. The global market size for CBD was predicted to exceed US$47 billion by 2028.

<span class="mw-page-title-main">Removal of cannabis from Schedule I of the Controlled Substances Act</span> Proposed changes to the legal status of cannabis in U.S. federal law

In the United States, the removal of cannabis from Schedule I of the Controlled Substances Act is a proposed legal and administrative change in cannabis-related law at the federal level. It has been proposed repeatedly since 1972. The category is the most tightly restricted category reserved for drugs that have "no currently accepted medical use.”

The Hemp Industries Association (HIA) is a non-profit trade group representing hemp companies, researchers and supporters in the United States and Canada. The group petitions for fair and equal treatment of industrial hemp. Since 1994, the HIA has been dedicated to education, industry development, and the accelerated expansion of hemp world market supply and demand.

<span class="mw-page-title-main">THC-O-acetate</span> Acetate ester of tetrahydrocannabinol (THC)

THC acetate ester is the acetate ester of THC. It is a metabolic pro-drug, with its subjective effects being felt around 30 minutes after ingestion.

<span class="mw-page-title-main">Legal history of cannabis in the United States</span>

In the United States, increased restrictions and labeling of cannabis as a poison began in many states from 1906 onward, and outright prohibitions began in the 1920s. By the mid-1930s cannabis was regulated as a drug in every state, including 35 states that adopted the Uniform State Narcotic Drug Act. The first national regulation was the Marihuana Tax Act of 1937.

<span class="mw-page-title-main">Cannabis in the United States</span> Legality, use, culture, market and production of cannabis in the United States

The use, sale, and possession of cannabis over 0.3% THC in the United States, despite laws in many states permitting it under various circumstances, is illegal under federal law. As a Schedule I drug under the federal Controlled Substances Act (CSA) of 1970, cannabis over 0.3% THC is considered to have "no accepted medical use" and have a high potential for abuse and physical or psychological dependence. Cannabis use is illegal for any reason, with the exception of FDA-approved research programs. However, individual states have enacted legislation permitting exemptions for various uses, including medical, industrial, and recreational use.

The Industrial Hemp Farming Act of 2009, introduced during the 111th United States Congress by House Republican Ron Paul of Texas) and House Democrat Barney Frank of Massachusetts) on April 2, 2009, sought to clarify the differences between marijuana and industrial hemp as well as repeal federal laws that prohibit cultivation of industrial, but only for research facilities of higher education from conducting research. Industrial hemp is the non-psychoactive, low-THC, oil-seed and fibers varieties of, predominantly, the cannabis sativa plant. Hemp is a sustainable resource that can be used to create thousands of different products including fuel, fabrics, paper, household products, and food and has been used for hundreds of centuries by civilizations around the world. If H.R.1866 passes American farmers will be permitted to compete in global hemp markets. On March 10, 2009, both Paul and Frank wrote a letter to their Congressional colleagues urging them to support the legislation. This bill was previously introduced in 2005 under the title of Industrial Hemp Farming Act of 2005.

<span class="mw-page-title-main">Medical cannabis in the United States</span> Use of cannabis for medical purposes in the United States

In the United States, the use of cannabis for medical purposes is legal in 38 states, four out of five permanently inhabited U.S. territories, and the District of Columbia, as of March 2023. Ten other states have more restrictive laws limiting THC content, for the purpose of allowing access to products that are rich in cannabidiol (CBD), a non-psychoactive component of cannabis. There is significant variation in medical cannabis laws from state to state, including how it is produced and distributed, how it can be consumed, and what medical conditions it can be used for.

<span class="mw-page-title-main">Hash oil</span> Oleoresin obtained by the extraction of cannabis or hashish

Hash oil or cannabis oil is an oleoresin obtained by the extraction of cannabis or hashish. It is a cannabis concentrate containing many of its resins and terpenes – in particular, tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids. Hash oil is usually consumed by smoking, vaporizing or eating. Preparations of hash oil may be solid or colloidal depending on both production method and temperature and are usually identified by their appearance or characteristics. Color most commonly ranges from transparent golden or light brown, to tan or black. There are various extraction methods, most involving a solvent, such as butane or ethanol.

<span class="mw-page-title-main">Cannabis in Colorado</span> Overview of the use and culture of cannabis in Colorado, U.S.

Cannabis in Colorado has been legal for medical use since 2000 and for recreational use since late 2012. On November 7, 2000, 54% of Colorado voters approved Amendment 20, which amended the State Constitution to allow the use of marijuana in the state for approved patients with written medical consent. Under this law, patients may possess up to 2 ounces (57 g) of medical marijuana and may cultivate no more than six marijuana plants. Patients who were caught with more than this in their possession could argue "affirmative defense of medical necessity" but were not protected under state law with the rights of those who stayed within the guidelines set forth by the state. The Colorado Amendment 64, which was passed by voters on November 6, 2012, led to recreational legalization in December 2012 and state-licensed retail sales in January 2014. The policy has led to cannabis tourism. There are two sets of policies in Colorado relating to cannabis use: those for medicinal cannabis and for recreational drug use along with a third set of rules governing hemp.

<span class="mw-page-title-main">Timeline of cannabis laws in the United States</span> Historical list in chronological order of U.S. cannabis law

The legal history of cannabis in the United States began with state-level prohibition in the early 20th century, with the first major federal limitations occurring in 1937. Starting with Oregon in 1973, individual states began to liberalize cannabis laws through decriminalization. In 1996, California became the first state to legalize medical cannabis, sparking a trend that spread to a majority of states by 2016. In 2012, Washington and Colorado became the first states to legalize cannabis for recreational use.

<span class="mw-page-title-main">Charlotte's Web (cannabis)</span> Strain of medical marijuana

Charlotte's Web is a brand of high-cannabidiol (CBD), low-tetrahydrocannabinol (THC) products derived from industrial hemp and marketed as dietary supplements and cosmetics under federal law of the United States. It is produced by Charlotte's Web, Inc. in Colorado. Hemp-derived products do not induce the psychoactive "high" typically associated with recreational marijuana strains that are high in THC. Charlotte's Web hemp-derived products contain less than 0.3% THC.

<span class="mw-page-title-main">Cannabis in Nebraska</span> Legality, use and culture of cannabis in the U.S. state of Nebraska

Cannabis in Nebraska is fully illegal, but first offense for possession of small amounts was reduced to a civil infraction in 1979.

<span class="mw-page-title-main">Cannabis in Iowa</span> Legality, use and culture of cannabis in the U.S. state of Iowa

Cannabis in Iowa is illegal for recreational use if classified as marijuana but consumable hemp products including CBD products are legal for consumers to possess and registered retailers to sell. Possession of even small amounts of marijuana is a misdemeanor crime. The state has a medical program for patients with qualifying debilitating medical conditions that allows for the legal sale and possession of no more than 4.5g of THC per patient every 90-day period. Allowed modes of consumption are oral & topical forms including, but not limited to; tablets and tinctures, nebulizable inhalable forms, suppositories, and vaporization.

<span class="mw-page-title-main">Cannabis in Texas</span> Overview of the use and culture of cannabis in Texas, U.S.

Cannabis in Texas is illegal for recreational use. Possession of up to two ounces is a class B misdemeanor, punishable by up to 180 days in prison and a fine of up to $2000. Several of the state's major municipalities have enacted reforms to apply lesser penalties or limit enforcement, however.

<span class="mw-page-title-main">Glossary of cannabis terms</span>

Terms related to cannabis include:

<span class="mw-page-title-main">Cannabis concentrate</span> Preparation of cannabis

Cannabis concentrate is a tetrahydrocannabinol (THC) and/or cannabidiol (CBD) concentrated mass. Cannabis concentrates contain high THC levels that range from 40% to over 90%, stronger in THC content than high-grade marijuana, which normally measures around 20% THC levels.

The Hemp Farming Act of 2018 was a proposed law to remove hemp from Schedule I controlled substances and making it an ordinary agricultural commodity. Its provisions were incorporated in the 2018 United States farm bill that became law on December 20, 2018.

<span class="mw-page-title-main">Outline of cannabis</span> Overview of and topical guide to cannabis

The following outline is provided as an overview of and topical guide to the plant Cannabis sativa and its relatives Cannabis indica and Cannabis ruderalis, the drug cannabis (drug) and the industrial product hemp.

References

  1. 1 2 3 "FindLaw's United States Ninth Circuit case and opinions". Findlaw. Retrieved 2019-05-08.
  2. ↑ Wallace, Alicia (2017-07-05). "Legality of CBD oil on trial in lawsuit challenging DEA in federal courts". The Cannabist . The Denver Post. Retrieved 2018-04-27.
  3. ↑ "DEA seeks dismissal of hemp industry lawsuit fighting drug code for "marihuana extracts"". Hoban Law Group. 2017-01-13. Retrieved 2018-04-27.
  4. ↑ Larry K. Houck; Riëtte van Laack (January 24, 2017). "Hemp Industries Association Files Petition Against DEA Marijuana Extract Rule Implementation". FDA Law Blog. Hyman, Phelps & McNamara. Retrieved 2018-04-27.
  5. ↑ Aleta Labak (June 2, 2017), "DEA seeks dismissal of hemp industry lawsuit fighting drug code for "marihuana extracts"", The Denver Post
  6. ↑ Clarification of the New Drug Code (7350) for Marijuana Extract, DEA Diversion Control Division, March 2017
  7. ↑ Alicia Wallace (February 15, 2018), "Federal appeals court hears hemp industry lawsuit challenging DEA's position on CBD", The Cannabist, The Denver Post
  8. ↑ amicus brief via Rep. Jared Polis, House official website


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.